Highbridge Capital Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Hold |
0
| – | – | – | 1110 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 1081 |
|
|
2017
Q2 | – | Sell |
-95,287
| Closed | -$496K | – | 1147 |
|
|
2017
Q1 | $496K | Buy |
+95,287
| New | +$496K | 0.01% | 722 |
|
|
2016
Q3 | – | Sell |
-69,404
| Closed | -$402K | – | 1310 |
|
|
2016
Q2 | $402K | Buy |
+69,404
| New | +$402K | 0.01% | 740 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 1095 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 1088 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 1094 |
|
|
2015
Q2 | – | Sell |
-23,847
| Closed | -$375K | – | 1056 |
|
|
2015
Q1 | $375K | Buy |
+23,847
| New | +$375K | 0.01% | 628 |
|
|
2014
Q4 | – | Sell |
-67,194
| Closed | -$724K | – | 977 |
|
|
2014
Q3 | $724K | Buy |
+67,194
| New | +$724K | 0.01% | 580 |
|
|
2013
Q4 | – | Sell |
-10,270
| Closed | -$109K | – | 916 |
|
|
2013
Q3 | $109K | Buy |
+10,270
| New | +$109K | ﹤0.01% | 861 |
|